journal article·2023-06-27Open access

Evaluation of the Safety and Gastrointestinal Migration of Guanidinylated Chitosan after Oral Administration to Rats

Nowshin Farzana Khan, Hideaki Nakamura, Hironori Izawa, Shinsuke Ifuku, Daisuke Kadowaki, Masaki Otagiri, Makoto Anraku

Abstract

Arginine-rich membrane-permeable peptides (APPs) can be delivered to cells by forming complexes with various membrane-impermeable bioactive molecules such as proteins. We recently reported on the preparation of guanidinylated chitosan (GCS) that mimics arginine peptides, using chitosan, a naturally occurring cationic polysaccharide, and confirmed that it enhances protein permeability in an in vitro cell system. However, studies on the in vivo safety of GCS are not available. To address this, we evaluated the in vivo safety of GCS and its translocation into the gastrointestinal tract in rats after a single oral administration of an excessive dose (500 mg/kg) and observed changes in body weight, major organ weights, and organ tissue sections for periods of up to 2 weeks. The results indicated that GCS causes no deleterious effects. The results of an oral administration of rhodamine-labeled chitosan and an evaluation of its migration in the gastrointestinal tract suggested that the disappearance of rhodamine-labeled GCS from the body appeared to be slower than that of the non-dose group and pre-guanidinylated chitosan due to its mucoadhesive properties. In the future, we plan to investigate the use of GCS to improve absorption using Class III and IV drugs, which are poorly water-soluble as well as poorly membrane-permeable.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · RNA Interference and Gene Delivery · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Nishi-ku, Kumamoto 860-0082, Japan

Faculty of Engineering, University of Miyazaki, 1-1 Gakuen Kibanadai-Nishi, Miyazaki 889-2192, Japan

Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan

References (22)

Show source-provided references
1. Chitosan and its use as a pharmaceutical excipient10.1023/A:1011929016601 ↗
2. Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies10.1016/j.carbpol.2018.07.016 ↗
3. Preparation of chitin nanofibers for biomedical application
4. Biomaterials based on chitin and chitosan in wound dressing applications10.1016/j.biotechadv.2011.01.005 ↗
5. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis10.1007/s11095-016-2094-y ↗
6. Oe, T., Dechojarassri, D., Kakinoki, S., Kawasaki, H., Furuik, e.T., and Tamura, H. (2023). Microwave-Assisted Incorporation of AgNP into Chitosan-Alginate Hydrogels for Antimicrobial Applications. J. Funct. Biomater., 14.10.3390/jfb14040199 ↗
7. Hypocholesterolemic effect of chitosan in adult males10.1271/bbb.57.1439 ↗
8. Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia10.3390/ijms160817445 ↗
9. Preparation and evaluation of freeze dried surface-deacetylated chitin nanofiber/sacran pellets for use as an extended-release excipient10.1016/j.ijbiomac.2018.11.225 ↗
10. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans
11. Influence of molecular weight on oral absorption of water soluble chitosans10.1016/j.jconrel.2004.10.012 ↗
12. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats10.1016/j.ijpharm.2008.03.016 ↗
13. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats10.1016/j.ijpharm.2014.03.010 ↗
14. Guanidinylated chitosan inspired by arginine-rich cell-penetrating peptides10.1016/j.ijbiomac.2018.12.138 ↗
15. Izawa, H., Kinai, M., Ifuku, S., Morimoto, M., and Saimoto, H. (2019). Guanidinylation of Chitooligosaccharides Involving Internal Cyclization of the Guanidino Group on the Reducing End and Effect of Guanidinylation on Protein Binding Ability. Biomolecules, 9.10.3390/biom9070259 ↗
16. Izawa, H., Yagi, A., Umemoto, R., and Ifuku, S. (2023). Water-soluble guanidinylated chitosan: A candidate material for protein delivery systems. Polym. J., 1–11.10.1038/s41428-023-00787-4 ↗
17. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery10.1517/17425247.2016.1125879 ↗
18. Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics10.1080/14712598.2021.1823368 ↗
19. Functional Peptides That Target Biomembranes: Design and Modes of Action10.1248/cpb.c21-00140 ↗
20. Current Understanding of Direct Translocation of Arginine-Rich Cell-Penetrating Peptides and Its Internalization Mechanisms10.1248/cpb.c16-00505 ↗
21. Sakamoto, K., Kitano, T., Kuwahara, H., Tedani, M., Aburai, K., Futaki, S., Abe, M., Sakai, H., Ohtaka, H., and Yamashita, Y. (2020). Effect of Vesicle Size on the Cytolysis of Cell-Penetrating Peptides (CPPs). Int. J. Mol. Sci., 21.10.3390/ijms21197405 ↗
22. Sakamoto, K., Morishita, T., Aburai, K., Sakai, K., Abe, M., Nakase, I., Futaki, S., and Sakai, H. (2020). Key Process and Factors Controlling the Direct Translocation of Cell-Penetrating Peptide through Bio-Membrane. Int. J. Mol. Sci., 21.10.3390/ijms21155466 ↗